Checking your sign-in status…

Private workspace

Finance

Research, portfolio tools, and market analysis in one place.

Finance home
Back to US Equities

US Equities · Finance research note

TSN — Tyson Foods

Research and analysis only
View analysis Browse US Equities

Evidence and analysis

Research evidence pack

Source-backed valuation visuals

Loading verified snapshot
Loading verified market, valuation, and statement data.

2. Company Fundamentals

2.1 Competitiveness

Metric Value
Operating Margins 3.64%
Profit Margins 0.81%
Return on Equity 2.62%
Return on Assets 2.47%
Free Float 0.27B
Dividend Yield 3.53%
Short Int % Utilisation 3.53%

2.2 Growth

Metric Value
Revenue Growth 4.4%
Free Cash Flow 1.03B
EBITDA 10.13 (Ratio)
Enterprise Value 27.45B
EV/Revenue 0.49
EV/EBITDA 10.13

Revenue growth of 4.4% suggests mature or challenged top-line momentum.

2.3 Management

Role Metric
Consensus Rating N/A

2.4 Return

Metric Value
Expected Return (Ann.)* 9.54%
Risk / Std Dev (Ann.)* 25.66%
1-Year Price Return* 5.98%

Latest Market Data (as of 2026-08-14, US Eastern time):

Metric Value
Last Price $58.17
52-Week Range $50.56 – $69.48
Observation Count 251 trading days

The return and risk statistics use daily adjusted closes from the retrieved one-year series and annualise daily moments using 252 trading days. The last price is the latest regular-market price reported for the stated date. Source: Yahoo Finance market data.

DuPont Model Analysis

The DuPont model decomposes return on equity (ROE) into three operating and capital-structure drivers:

ROE = Net Margin × Asset Turnover × Equity Multiplier

The comparison uses the latest two comparable annual periods available for the issuer, with reported statement amounts shown in US$. Revenue and net income are income-statement flows; total assets and shareholders’ equity are year-end balance-sheet figures. This is a simplified year-end-balance DuPont comparison rather than an average-balance ROE calculation.

DuPont component Calculation FY2025 FY2024
Revenue Reported revenue $54.44B $53.31B
Net income Reported net income $474.00M $800.00M
Total assets Year-end reported balance $36.66B $37.10B
Shareholders’ equity Year-end reported balance $18.09B $18.39B
Net margin Net income ÷ revenue 0.87% 1.50%
Asset turnover Revenue ÷ total assets 1.4851x 1.4369x
Equity multiplier Total assets ÷ shareholders’ equity 2.0270x 2.0174x
ROE Net margin × asset turnover × equity multiplier 2.62% 4.35%

Source: Yahoo Finance annual statements. Values are based on the two latest comparable annual periods returned by the source; fiscal period labels use the statement period-end year.

2.5 FCFF DCF Valuation

Valuation basis: This research model follows a five-year, unlevered FCFF DCF. It starts from reported annual operating inputs, forecasts revenue and operating cash conversion under an explicit mechanical policy, discounts FCFF at WACC, applies a Gordon-growth terminal value, and bridges enterprise value to an indicative common-equity value per share. It is an analytical estimate rather than a recommendation or personalised target price.

Step 1 — Forecast Operating Profit and NOPAT

Reported operating input Value
Revenue $54.44B
Prior annual revenue $53.31B
EBIT $1.22B
Tax rate 34.10%
NOPAT = EBIT × (1 − tax rate) $802.66M
Forecast start-growth basis 2.12%
Forecast policy latest reported annual revenue growth, bounded to -10.00% / 15.00%

Step 2 — Calculate FCFF

Current FCFF building block Value
NOPAT $802.66M
Add: depreciation & amortisation $1.36B
Less: capital expenditure -$978.00M
Less/(add): working-capital cash-flow movement -$106.00M
Current unlevered FCFF $1.08B

Explicit FCFF forecast

Forecast year Revenue growth NOPAT D&A Capex Change in NWC FCFF Present value
1 2.12% $819.71M $1.39B -$998.77M -$108.25M $1.10B $1.07B
2 2.22% $837.88M $1.42B -$1.12B -$110.65M $1.03B $945.05M
3 2.31% $857.25M $1.45B -$1.25B -$113.21M $948.57M $825.68M
4 2.41% $877.88M $1.49B -$1.38B -$115.93M $866.67M $713.67M
5 2.50% $899.83M $1.53B -$1.53B -$118.83M $780.99M $608.40M

Step 3 — Determine the Discount Rate (WACC)

WACC input Value
Risk-free rate 4.71%
Equity risk premium assumption 5.50%
Beta 0.38
Cost of equity 6.79%
Pre-tax cost of debt 4.82%
WACC 5.71%
WACC validation requires assumption review

Step 4 — Estimate Terminal Value

Terminal-value input Value
Perpetuity growth rate 2.50%
Terminal value $24.97B
Implied terminal EV / EBITDA 8.63x
Terminal value as % of enterprise value 81.95%

Step 5 — Discount Cash Flows to Enterprise Value

Enterprise-value component Value
Present value of explicit FCFF $4.17B
Present value of terminal value $18.92B
Indicated enterprise value $23.08B
Discounting convention mid-year for explicit FCFF; terminal value discounted at year-end five

Step 6 — Convert Enterprise Value to Equity Value

Equity bridge Value
Indicated enterprise value $23.08B
Less: gross interest-bearing debt $8.83B
Add: cash and equivalents $1.23B
Add: affiliate investments $0.00
Less: minority interests $142.00M
Indicated common equity value $15.34B

Step 7 — Calculate Indicative Value Per Share

Per-share output Value
Shares used 357,000,000.00
Share-count basis reported diluted weighted-average shares
Current market price $58.51
DCF indicative value per share $42.96
Indicative value vs. market price -26.56%

Model Integrity Checks

Check Result
Perpetuity growth is below the risk-free rate pass
Perpetuity growth is below WACC pass
WACC is within the configured operating-company range review required
Terminal-year FCFF is positive pass
Terminal capex converges to D&A pass
Terminal-value concentration within review band
Implied price differs from spot by more than 30% within review band

2.6 Investor-Style Research Screen

Educational screen Result
Buffett-inspired cash-quality checks 4/4 evidenced checks
Lynch-inspired balance-and-growth checks 4/4 evidenced checks

Data lineage: Yahoo Finance public market and reported-statement data; retrieval timestamp: 2026-08-18 17:51:47.787070 UTC; latest reported fiscal period: 2025-09-30 00:00:00. Default assumptions: five-year forecast, mid-year discounting for explicit FCFF, a maximum 2.50% perpetuity-growth rate below both WACC and the risk-free rate, historical operating-ratio persistence, and capex convergence to D&A by year five. No sell-side consensus or management guidance is substituted for reported inputs. This is research and analysis only, not personalized financial advice.

2.7 Quantitative Factor Diagnostics

Model basis: Daily issuer USD excess returns are regressed in-sample using ordinary least squares on matching regional Fama–French factors. FF3 estimates market, size, and value loadings; FF5 adds profitability and investment. Coefficients are descriptive historical exposures, not predictions.

Estimation input Value
Regional factor set US
Factor-return currency USD
Issuer-return basis USD adjusted total return
Estimation window 2025-08-19 to 2026-06-30
Aligned daily observations 217
Minimum observation requirement 120
Currency conversion for HK listings not required

Fama–French Three-Factor and Five-Factor Results

Diagnostic FF3 FF5
Annualised alpha -1.17% 10.03%
Adjusted R² 0.03 0.06
Annualised residual volatility 24.84% 24.34%
Factor loading (t-statistic) FF3 FF5
Market excess return (Mkt-RF) -0.03 (-0.18) 0.19 (1.13)
Size (SMB) 0.52 (2.61) 0.64 (3.04)
Value (HML) 0.15 (0.85) 0.06 (0.31)
Profitability (RMW) NM 0.51 (2.95)
Investment (CMA) NM -0.07 (-0.24)

Definitions: Mkt-RF is the market return less the risk-free rate; SMB is small minus big; HML is high minus low book-to-market; RMW is robust minus weak profitability; CMA is conservative minus aggressive investment. Factor returns are sourced from the Kenneth R. French Data Library; issuer adjusted-return history is sourced from Yahoo Finance. For Hong Kong listings, adjusted HKD prices are converted into USD with daily USD/HKD closes before return calculation to match the USD regional factor basis. This is an in-sample historical regression; coefficients and t-statistics do not establish causation or predict future returns. This is research and analysis only, not personalized financial advice.

us-equitystockequitytsnconsumer-staplespackaged-foods--meatsnasdaq